← Back to Search

Behavioural Intervention

Nudges for Smoking Cessation in Mental Illness (ISRAISE Trial)

N/A

Waitlist Available

Led By Li-Shiun Chen, M.D., MPH, ScD

Research Sponsored by Washington University School of Medicine

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 3 months, 6 months

Awards & highlights

ISRAISE Trial Summary

This trial will study the effectiveness of a multi-level intervention to help people with serious mental illness quit smoking.

Who is the study for?

This trial is for adults over 18 who are patients at a participating clinic, speak and understand English, and currently smoke more than five cigarettes per day. It's not for those actively using or prescribed smoking cessation medication in the past month.Check my eligibility

What is being tested?

'Nudges to Quit' is being tested as a way to help people with serious mental illness quit smoking by increasing engagement between patients, case workers, and pharmacists. This pilot study will inform a larger future trial.See study design

What are the potential side effects?

Since 'Nudges to Quit' involves behavioral strategies rather than medications, there may be no direct medical side effects; however, participants might experience stress or anxiety related to quitting smoking.

ISRAISE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 3 months, 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 3 months, 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 3 months, 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Secondary outcome measures

Abstinence outcomes across multiple time points

Proportion of patients receiving any tobacco treatment

Quit attempts

+3 more

ISRAISE Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: "Nudges to Quit"Experimental Treatment1 Intervention

Patients will receive a multilevel intervention that includes reminders to care team to increase tobacco treatment engagement.

Group II: Usual CareActive Control1 Intervention

Patients will receive general brief advice about smoking cessation at patient tobacco treatment needs assessment then receive the intervention at 3 months.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor

1,931 Previous Clinical Trials

2,299,649 Total Patients Enrolled

4 Trials studying Smoking

4,609 Patients Enrolled for Smoking

National Cancer Institute (NCI)NIH

13,654 Previous Clinical Trials

40,933,093 Total Patients Enrolled

63 Trials studying Smoking

54,043 Patients Enrolled for Smoking

Li-Shiun Chen, M.D., MPH, ScDPrincipal InvestigatorWashington University School of Medicine

1 Previous Clinical Trials

915 Total Patients Enrolled

1 Trials studying Smoking

915 Patients Enrolled for Smoking

Media Library

Nudges (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05952401 — N/A

Smoking Research Study Groups: Usual Care, "Nudges to Quit"

Smoking Clinical Trial 2023: Nudges Highlights & Side Effects. Trial Name: NCT05952401 — N/A

Nudges (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05952401 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical research accepting new participants?

"This study, which was initially published on the 15th of August 2023 and last modified on the 11th of July 2023, is no longer recruiting patients. However, clinicaltrials.gov reveals that 589 other trials are still actively seeking applicants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Implementation Science to Reduce the Disparity in Tobacco Treatment Among Individuals With Serious Mental Illness

2024. "Implementation Science to Reduce the Disparity in Tobacco Treatment Among Individuals With Serious Mental Illness". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05952401.

All > Mental Illness